• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open.

作者信息

Raghu Ganesh, Noth Imre, Martinez Fernando

机构信息

Center for Interstitial Lung Disease, University of Washington, Seattle, WA 98195, USA.

University of Chicago, Chicago, IL, USA.

出版信息

Lancet Respir Med. 2017 Jan;5(1):e1-e2. doi: 10.1016/S2213-2600(16)30327-7.

DOI:10.1016/S2213-2600(16)30327-7
PMID:28000596
Abstract
摘要

相似文献

1
N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open.N-乙酰半胱氨酸治疗特发性肺纤维化：大门依然敞开。
Lancet Respir Med. 2017 Jan;5(1):e1-e2. doi: 10.1016/S2213-2600(16)30327-7.
2
N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open-Authors' reply.用于特发性肺纤维化的N-乙酰半胱氨酸：大门仍然敞开——作者回复
Lancet Respir Med. 2017 Jan;5(1):e3. doi: 10.1016/S2213-2600(16)30418-0.
3
Efficacy and safety of inhaled N-acetylcysteine in idiopathic pulmonary fibrosis: A prospective, single-arm study.吸入性N-乙酰半胱氨酸治疗特发性肺纤维化的疗效与安全性：一项前瞻性单臂研究。
Respir Investig. 2016 May;54(3):156-61. doi: 10.1016/j.resinv.2015.10.001. Epub 2015 Dec 15.
4
Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.N-乙酰半胱氨酸治疗特发性肺纤维化的疗效：一项系统评价和荟萃分析。
Medicine (Baltimore). 2016 May;95(19):e3629. doi: 10.1097/MD.0000000000003629.
5
Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: a case-control study.吡非尼酮与吸入用N-乙酰半胱氨酸联合治疗晚期特发性肺纤维化的有效性：一项病例对照研究。
Respirology. 2015 Apr;20(3):445-52. doi: 10.1111/resp.12477. Epub 2015 Feb 2.
6
Effect of inhaled N-acetylcysteine monotherapy on lung function and redox balance in idiopathic pulmonary fibrosis.吸入性N-乙酰半胱氨酸单一疗法对特发性肺纤维化肺功能和氧化还原平衡的影响。
Respir Investig. 2016 May;54(3):170-8. doi: 10.1016/j.resinv.2015.11.004. Epub 2015 Dec 30.
7
A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis.雾化吸入N-乙酰半胱氨酸治疗特发性肺纤维化的一项初步研究。
Respirology. 2005 Sep;10(4):449-55. doi: 10.1111/j.1440-1843.2005.00725.x.
8
Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis.吸入乙酰半胱氨酸单药治疗早期特发性肺纤维化患者的疗效。
Respirology. 2012 Apr;17(3):467-77. doi: 10.1111/j.1440-1843.2012.02132.x.
9
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.乙酰半胱氨酸治疗特发性肺纤维化的随机试验。
N Engl J Med. 2014 May 29;370(22):2093-101. doi: 10.1056/NEJMoa1401739. Epub 2014 May 18.
10
Idiopathic pulmonary fibrosis: prime time for a precision-based approach to treatment with -acetylcysteine.特发性肺纤维化：采用基于精准医学的N-乙酰半胱氨酸治疗的黄金时期。
Eur Respir J. 2021 Jan 5;57(1). doi: 10.1183/13993003.03551-2020. Print 2021 Jan.

引用本文的文献

1
N-Acetyl cysteine exhibits antimicrobial and anti-virulence activity against Salmonella enterica.N-乙酰半胱氨酸对肠炎沙门氏菌具有抗菌和抗毒力活性。
PLoS One. 2025 Jan 7;20(1):e0313508. doi: 10.1371/journal.pone.0313508. eCollection 2025.
2
Redox Pathogenesis in Rheumatic Diseases.风湿性疾病中的氧化还原发病机制。
ACR Open Rheumatol. 2024 Jun;6(6):334-346. doi: 10.1002/acr2.11668. Epub 2024 Apr 25.
3
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress.N-乙酰半胱氨酸（NAC）在氧化应激相关疾病中的多效治疗作用。
Curr Neuropharmacol. 2021;19(8):1202-1224. doi: 10.2174/1570159X19666201230144109.
4
Transcriptomic changes involved in the dedifferentiation of myofibroblasts derived from the lung of a patient with idiopathic pulmonary fibrosis.特发性肺纤维化患者肺来源成纤维细胞去分化过程中转录组变化。
Mol Med Rep. 2020 Aug;22(2):1518-1526. doi: 10.3892/mmr.2020.11218. Epub 2020 Jun 10.
5
Diverse Injury Pathways Induce Alveolar Epithelial Cell CCL2/12, Which Promotes Lung Fibrosis.多种损伤途径诱导肺泡上皮细胞 CCL2/12，进而促进肺纤维化。
Am J Respir Cell Mol Biol. 2020 May;62(5):622-632. doi: 10.1165/rcmb.2019-0297OC.
6
Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF).特发性肺纤维化（IPF）的药物治疗及辅助治疗
J Thorac Dis. 2019 Sep;11(Suppl 14):S1740-S1754. doi: 10.21037/jtd.2019.04.62.
7
Chinese Herbal Medicines Compared with N-Acetylcysteine for the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review of Randomized Controlled Trials.与N-乙酰半胱氨酸相比，中药治疗特发性肺纤维化的随机对照试验系统评价
Evid Based Complement Alternat Med. 2019 Jun 13;2019:5170638. doi: 10.1155/2019/5170638. eCollection 2019.
8
Chinese herbal medicines compared with N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: Protocol for a systematic review.与N-乙酰半胱氨酸相比，中药治疗特发性肺纤维化的系统评价方案
Medicine (Baltimore). 2018 Nov;97(44):e13077. doi: 10.1097/MD.0000000000013077.
9
Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review.特发性肺纤维化中氧化应激生物标志物的评估及治疗应用：系统评价。
Respir Res. 2018 Mar 27;19(1):51. doi: 10.1186/s12931-018-0754-7.
10
Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential.特发性肺纤维化的药物治疗：现状与未来潜力。
Eur Respir Rev. 2017 Sep 27;26(145). doi: 10.1183/16000617.0071-2017. Print 2017 Sep 30.